Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.

Neuropsychological and neurophysiological characterization of mild cognitive impairment and Alzheimer's disease in Down syndrome.

García-Alba J, Ramírez-Toraño F, Esteba-Castillo S, Bruña R, Moldenhauer F, Novell R, Romero-Medina V, Maestú F, Fernández A.

Neurobiol Aging. 2019 Aug 3;84:70-79. doi: 10.1016/j.neurobiolaging.2019.07.017. [Epub ahead of print]

PMID:
31518951
2.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
3.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
4.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
5.

Effects of storage over a 36-month period on coagulation factors in a canine plasma product obtained by use of plasmapheresis.

Donahue ME, Fernandez AL.

Am J Vet Res. 2019 Jun;80(6):578-585. doi: 10.2460/ajvr.80.6.578.

PMID:
31140844
6.

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.

Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bøhmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, Noè A, Schwende H, Bao W, Butylin D, Pascual-Figal D; TRANSITION Investigators.

Eur J Heart Fail. 2019 Aug;21(8):998-1007. doi: 10.1002/ejhf.1498. Epub 2019 May 27.

7.

Ligand-Based Virtual Screening Using Graph Edit Distance as Molecular Similarity Measure.

Garcia-Hernandez C, Fernández A, Serratosa F.

J Chem Inf Model. 2019 Apr 22;59(4):1410-1421. doi: 10.1021/acs.jcim.8b00820. Epub 2019 Apr 10.

PMID:
30920214
8.

Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.

Maestú F, Cuesta P, Hasan O, Fernandéz A, Funke M, Schulz PE.

Front Hum Neurosci. 2019 Mar 6;13:81. doi: 10.3389/fnhum.2019.00081. eCollection 2019.

9.

The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.

Maestú F, Cuesta P, Hasan O, Fernandéz A, Funke M, Schulz PE.

Front Hum Neurosci. 2019 Feb 5;13:17. doi: 10.3389/fnhum.2019.00017. eCollection 2019. Review. Erratum in: Front Hum Neurosci. 2019 Mar 06;13:81.

10.

Impact of origin-destination information in epidemic spreading.

Gómez S, Fernández A, Meloni S, Arenas A.

Sci Rep. 2019 Feb 19;9(1):2315. doi: 10.1038/s41598-019-38722-4.

11.

Vogt-Koyanagi-Harada Disease, a Rare Entity in Spain: The Challenge of Worldwide Immigration and Globalization.

Fernández AB, Moyano SP, Husein-ElAhmed H, Juárez AMA.

Eur J Case Rep Intern Med. 2018 Jul 26;5(7):000886. doi: 10.12890/2018_000886. eCollection 2018.

12.

Modern neuropsychological tests for a diversity of cultural contexts.

Fernandez AL.

Clin Neuropsychol. 2019 Feb;33(2):438-445. doi: 10.1080/13854046.2018.1560501. Epub 2019 Jan 21.

PMID:
30663506
13.
14.

RuII( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo.

Lenis-Rojas OA, Robalo MP, Tomaz AI, Carvalho A, Fernandes AR, Marques F, Folgueira M, Yáñez J, Vázquez-García D, López Torres M, Fernández A, Fernández JJ.

Inorg Chem. 2018 Nov 5;57(21):13150-13166. doi: 10.1021/acs.inorgchem.8b01270. Epub 2018 Oct 19.

PMID:
30339386
15.

BDNF Val66Met Polymorphism and Gamma Band Disruption in Resting State Brain Functional Connectivity: A Magnetoencephalography Study in Cognitively Intact Older Females.

Rodríguez-Rojo IC, Cuesta P, López ME, de Frutos-Lucas J, Bruña R, Pereda E, Barabash A, Montejo P, Montenegro-Peña M, Marcos A, López-Higes R, Fernández A, Maestú F.

Front Neurosci. 2018 Oct 2;12:684. doi: 10.3389/fnins.2018.00684. eCollection 2018.

16.

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.

Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators.

N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27.

17.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

18.

Physical activity effects on the individual alpha peak frequency of older adults with and without genetic risk factors for Alzheimer's Disease: A MEG study.

de Frutos-Lucas J, López-Sanz D, Zuluaga P, Rodríguez-Rojo IC, Luna R, López ME, Delgado-Losada ML, Marcos A, Barabash A, López-Higes R, Maestú F, Fernández A.

Clin Neurophysiol. 2018 Sep;129(9):1981-1989. doi: 10.1016/j.clinph.2018.06.026. Epub 2018 Jul 11.

PMID:
30031969
19.

Intrathoracic fracture-Dislocation of the shoulder.

Fernández AI, Fernández AG.

J Clin Orthop Trauma. 2018 Jun;9(Suppl 2):S54-S57. doi: 10.1016/j.jcot.2018.04.001. Epub 2018 Apr 9.

20.

Diimidazolium Halobismuthates [Dim]2[Bi2X10] (X = Cl-, Br-, or I-): A New Class of Thermochromic and Photoluminescent Materials.

García-Fernández A, Marcos-Cives I, Platas-Iglesias C, Castro-García S, Vázquez-García D, Fernández A, Sánchez-Andújar M.

Inorg Chem. 2018 Jul 2;57(13):7655-7664. doi: 10.1021/acs.inorgchem.8b00629. Epub 2018 Jun 12.

PMID:
29894172

Supplemental Content

Loading ...
Support Center